Literature DB >> 16369536

Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling.

Brian E Collins1, Brian A Smith, Per Bengtson, James C Paulson.   

Abstract

CD22 is a negative regulator of B cell signaling, an activity modulated by its interaction with glycan ligands containing alpha2-6-linked sialic acids. B cells deficient in the enzyme (ST6Gal I) that forms the CD22 ligand show suppressed BCR signaling. Here we report that mice deficient in both CD22 and its ligand (Cd22-/- St6gal1-/- mice) showed restored B cell receptor (BCR) signaling, suggesting that the suppressed signaling of St6gal1-/- cells is mediated through CD22. Coincident with suppressed BCR signaling, B cells lacking ST6Gal I showed a net redistribution of the BCR to clathrin-rich microdomains containing most of the CD22, resulting in a twofold increase in the localization of CD22 together with the BCR. These studies suggest an important function for the CD22-ligand interaction in regulating BCR signaling and microdomain localization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16369536     DOI: 10.1038/ni1283

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  62 in total

1.  Molecular phylogeny and functional genomics of beta-galactoside alpha2,6-sialyltransferases that explain ubiquitous expression of st6gal1 gene in amniotes.

Authors:  Daniel Petit; Anne-Marie Mir; Jean-Michel Petit; Christine Thisse; Philippe Delannoy; Rafael Oriol; Bernard Thisse; Anne Harduin-Lepers
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

2.  CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells.

Authors:  Mary K O'Reilly; Hua Tian; James C Paulson
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

3.  Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling.

Authors:  Francesca Gasparrini; Christoph Feest; Andreas Bruckbauer; Pieta K Mattila; Jennifer Müller; Lars Nitschke; Dennis Bray; Facundo D Batista
Journal:  EMBO J       Date:  2015-12-15       Impact factor: 11.598

4.  CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases : English version.

Authors:  T Tsubata
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

Review 5.  [CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases. German version].

Authors:  T Tsubata
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

Review 6.  Rethinking mechanisms of autoimmune pathogenesis.

Authors:  Shiv Pillai
Journal:  J Autoimmun       Date:  2013-06-25       Impact factor: 7.094

Review 7.  Siglecs as sensors of self in innate and adaptive immune responses.

Authors:  James C Paulson; Matthew S Macauley; Norihito Kawasaki
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

8.  ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling.

Authors:  Prabhjit K Grewal; Mark Boton; Kevin Ramirez; Brian E Collins; Akira Saito; Ryan S Green; Kazuaki Ohtsubo; Daniel Chui; Jamey D Marth
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 9.  Basic and clinical immunology of Siglecs.

Authors:  Stephan von Gunten; Bruce S Bochner
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

10.  Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation.

Authors:  Mehrab Nasirikenari; E V Chandrasekaran; Khushi L Matta; Brahm H Segal; Paul N Bogner; Amit A Lugade; Yasmin Thanavala; James J Lee; Joseph T Y Lau
Journal:  J Leukoc Biol       Date:  2009-12-09       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.